Abstract:AIMBoth development and progression of malignancies occur as a multistep process, requiring the activation of oncogenes and the inactivation of several tumor suppressor genes. The loss of heterozygosity (LOH) of tumor suppressor genes is believed to play a key role in carcinogenesis of colorectal cancer (CRC). In this study, we analyzed the LOH of seven loci on chromosome 22q13 in an effort to identify candidate tumor suppressor genes involved in colorectal carcinogenesis.METHODSMatched tumor and normal tissue DNA were analyzed by PCR using fluorescence-labeled polymorphic microsatellite markers in 83 CRC patients. PCR products were eletrophoresed and LOH was determined by calculating the peak height acquired through computer software. Comparisons between LOH frequency and clinicopathological features were performed by chi2 test. P<0.05 was considered as statistical significance.RESULTSThe average LOH frequency of chromosome 22q13 was 28.38%. The highest LOH frequency was 64.71% on D22S1160 locus, and the lowest was 21.43% on D22S1141 locus. We detected two obvious minimal deletion regions: one between markers D22S1171 and D22S274, the other flanked by markers D22S1160 and D22S1149, each about 2.7 and 1.8 cm, respectively. None had lost in all informative loci. LOH frequency on D22S1171 is 50% on distal colon, which was higher than that on proximal one (P = 0.020); on D22S114 locus, none LOH event occurred in patients with liver metastasis, whilst 46.94% occurred in patients without liver metastasis (P = 0.008); on D22S1160 locus, LOH frequency in lymph nodes metastasis patients was 83.33%, which was much higher than 43.75% without lymph nodes metastasis ones (P = 0.016). There was no statistical significance between clinicopathological features and other loci.CONCLUSIONThis study provides evidence of two minimal deletion regions, which may harbor putative tumor suppressor genes related to progression and metastasis in sporadic colorectal carcinoma on chromosome 22q13.

[Analysis on Loss of Heterozygosity of Chromosome 17p13.3 in Hepatocellular Carcinoma and Construction of Genomic Contig in the Deleted Region].

The minimum LOH region defined on chromosome 17p13.3 in human hepatocellular carcinoma with gene content analysis.

The Association of Frequent Allelic Loss on 17p13.1 with Early Metastastic Recurrence of Hepatocellular Carcinoma after Liver Transplantation

Loss of Heterozygosity on Chromosome 3p in Breast Cancer and Precancerous Lesion

Loss of Heterozygosity on Chromosome 10Q22-10Q23 and 22q 11.2- 22q 12.1 and P53 Gene in Primary Hepatocellular Carcinoma

Ioss of Heterozygosity on Chromosomes 8 and 16 in Primary Hepatocellular Carcinoma

Genetic Aberration in Primary Hepatocellular Carcinoma: Correlation Between P53 Gene Mutation and Loss-of-hetero- Zygosity on Chromosome 16Q21-Q23 and 9P21-P23

Loss of heterozygosity on chromosome 17p13.3 in ovarian cancer and cervical cancer

[Refined Mapping of Loss of Heterzygosity on 10Q23-24 in Sporadic Colorectal Carcinoma].

[Refined Deletion Mapping of Loss of Heterozygosity on 22q13 in Sporadic Colorectal Carcinoma].

[Loss of Heterozygosity Analysis to Define Putative Region Involved in Tumor Differentiation and Metastases in Sporadic Colorectal Cancer Patients].

Preliminary study on the loss of heterozygosity at 17p13 in gastric and colorectal cancers.

The Roles of Loss of Heterozygosity at 8p22 in the Molecular Classification of Patients with Hepatocellular Carcinoma, with Special Reference to Survival after Surgical Operation

[Loss of Heterozygosity of Plasma Circulating DNA from Hepatocellular Carcinoma Patients and Its Clinical Significance].

Relation of HCC to Loss of Heterozygosity

Loss of Heterozygosity Analysis on Chromosome 8p in Hepatocellular Carcinoma Based on Laser Capture Microdissection

[Refined Mapping of Loss of Heterozygosity of 1P36.33-36.31 in Sporadic Colorectal Carcinoma].

Loss of Heterozygosity on Chromosome 3p in Thyroid Tumors

Detailed Deletion Mapping of Loss of Heterozygosity on 22q13 in Sporadic Colorectal Cancer

The prognostic value of chromosomal loss of heterozygosity in molecular staging for TNM stage Ⅰ of hepatocellular carcinoma

The value of chromosomal loss of heterozygosity in prognosis prediction of hepatocellular carcinoma patients with curative resection